|
Thomas M. Spitznagel joined HGS in March 1998 as Group Leader Formulation. Dr. Spitznagel has moved through a number of positions of increasing responsibility including oversight of Analytical Development Drug Delivery Purification Sciences Fermentation and Cell Culture Sciences and Global Project Management. He was promoted to Vice President BioPharmaceutical Development in May 2008. Prior to joining HGS Dr. Spitznagel was a Senior Scientist at Nabi Biopharmaceuticals from 1996-1998 and a Staff Engineer at Genetics Institute from 1992-1996. During his tenure at Nabi Dr. Spitznagel was responsible for scale-up and development of the purification process for polysaccharide-protein conjugate vaccines. During his tenure at Genetics Institute Dr. Spitznagel was responsible for formulation and delivery system development for rhBMP-2 as well as finished product process development. Dr. Spitznagel earned his BS in Chemical Engineering at M.I.T and his Ph.D. in Chemical Engineering at the University of California Berkeley. | 